glp-1 kidney news disease receptor agonists in patients with chronic and either overweight or obesity GLP1 Receptor Agonists vs SGLT2-I – Real-World Evidence for GLP-1 Receptor

Patients should stop the medication and seek immediate medical attention for severe, persistent abdominal pain, intractable vomiting, jaundice, or signs of pancreatitis or gallbladder disease

People who have experienced a plateau on their GLP-1 medication or who are considering switching between medications should work with their healthcare provider rather than substituting a supplement for a pharmaceutical

This compound is supplied exclusively for research purposes and is not approved as a medicine, supplement, cosmetic, or therapeutic product

However, doctors and researchers soon noticed that many patients taking these medications also lost a lot of weight